Search - tctmd.com

Displaying 1 - 20 of 195

Sort: Relevancy | Date

News Daily News

US Societies Lay Out Requirements for Transcatheter Tricuspid Valve Procedures

Michael O'Riordan

March 27, 2026

News Daily News

In-Hospital STEMI Patients Face Reperfusion Delays and Worse Outcomes

Michael O'Riordan

February 06, 2026

News Daily News

FAME 2 at 10 Years: Less Urgent Revascularization With FFR-Guided PCI

Michael O'Riordan

January 26, 2026

News Daily News

Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators

Michael O'Riordan

January 22, 2026

News Daily News

Periprocedural MI Signals Worse Outcomes in Stented NSTE ACS Patients: MATRIX

Michael O'Riordan

January 15, 2026

News Daily News

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

Michael O'Riordan

December 23, 2025

News Daily News

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

Michael O'Riordan

September 23, 2025

$Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis$

News Daily News

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

Todd Neale

August 13, 2025

With MISSON Act, Veterans Get More Convenient but Potentially Worse CV Care

News Daily News

With MISSION Act, Veterans Get More Convenient but Potentially Worse CV Care

Yael L. Maxwell

August 08, 2025

News Daily News

Most PCIs in US Now Done With Radial Access

Michael O'Riordan

July 10, 2025

News Daily News

Trade-offs With Invasive Strategy in Older Patients With ACS: Meta-analysis

Michael O'Riordan

July 03, 2025

News Daily News

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Yael L. Maxwell

June 18, 2025

No Change in HF Outcomes When Private Equity Buys the Hospital

News Daily News

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Michael O'Riordan

June 16, 2025

News Daily News

Liberal Transfusion Strategy for Acute MI and Anemia Doesn’t Impact QoL

Michael O'Riordan

June 06, 2025

News Daily News EuroPCR 2025

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

Michael O'Riordan

May 28, 2025

News Daily News

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

Michael O'Riordan

May 01, 2025

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Daily News

SCAI Releases Practical, Technical Advice for Primary PCI in STEMI

Michael O'Riordan

October 10, 2024

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

Advertisement

US Societies Lay Out Requirements for Transcatheter Tricuspid Valve Procedures

In-Hospital STEMI Patients Face Reperfusion Delays and Worse Outcomes

FAME 2 at 10 Years: Less Urgent Revascularization With FFR-Guided PCI

Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators

Periprocedural MI Signals Worse Outcomes in Stented NSTE ACS Patients: MATRIX

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

With MISSION Act, Veterans Get More Convenient but Potentially Worse CV Care

Most PCIs in US Now Done With Radial Access

Trade-offs With Invasive Strategy in Older Patients With ACS: Meta-analysis

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Liberal Transfusion Strategy for Acute MI and Anemia Doesn’t Impact QoL

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Top Coronary Artery Disease News in 2024

SCAI Releases Practical, Technical Advice for Primary PCI in STEMI

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content